[go: up one dir, main page]

AR068408A1 - Pulverizacion de hormonas transdermicas - Google Patents

Pulverizacion de hormonas transdermicas

Info

Publication number
AR068408A1
AR068408A1 ARP080103941A ARP080103941A AR068408A1 AR 068408 A1 AR068408 A1 AR 068408A1 AR P080103941 A ARP080103941 A AR P080103941A AR P080103941 A ARP080103941 A AR P080103941A AR 068408 A1 AR068408 A1 AR 068408A1
Authority
AR
Argentina
Prior art keywords
branched
linear
substituted
alkyl group
cyclic chain
Prior art date
Application number
ARP080103941A
Other languages
English (en)
Inventor
R Saul Levinson
David Paul Miller
Original Assignee
Drugtech Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Drugtech Corp filed Critical Drugtech Corp
Publication of AR068408A1 publication Critical patent/AR068408A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Una composicion de pulverizacion transdérmica de estrogenos, que comprende: una cantidad terapéuticamente eficaz de un estrogeno; un potenciador de la penetracion; y un disolvente volátil, donde el potenciador de la penetracion se selecciona entre terpenos, terpenoides, aceites esenciales, pirrolidonas, azonas sulfoxidos, amidas, alcoholes, glicoles, glicéridos, derivados de aminoácidos, fosfolípidos, tensioactivos y ácidos grasos y ésteres de los mismos que tienen la formula (1) R1-C(=O)-O-H o formula (2) R2-C(=O)-R3 en la que: R1 se selecciona entre un grupo alquilo que contiene una cadena lineal, ramificada o cíclica o un grupo alquilo sustituido C8-20, y un grupo alquenilo que contiene una cadena lineal, ramificada o cíclica o un grupo alquenilo sustituido C8-20; R2 se selecciona entre un grupo alquilo que contiene una cadena lineal, ramificada o cíclica o un grupo alquilo sustituido C8-20, y un grupo alquenilo que contiene una cadena lineal, ramificada o cíclica o un grupo alquenilo sustituido C8-20; y R3 se selecciona entre alquilo inferior, alquenilo inferior, un grupo alquilo que contiene una cadena lineal, ramificada o cíclica o un grupo alquilo sustituido C6-14, y un grupo alquenilo que contiene una cadena lineal, ramificada o cíclica o un grupo alquenilo sustituido C6-14, y los alquilos sustituidos o alquenilos sustituidos tienen de 1 a 4 sustituyentes seleccionados entre hidroxi, halo, oxo, alcoxi y amino; y donde, cuando se aplica a la piel, la composicion proporciona un flujo transdérmico en vivo de estrogenos de aproximadamente 0,03 a aproximadamente 0,3microgramos/cm2 por hora.
ARP080103941A 2007-09-14 2008-09-11 Pulverizacion de hormonas transdermicas AR068408A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US99375507P 2007-09-14 2007-09-14

Publications (1)

Publication Number Publication Date
AR068408A1 true AR068408A1 (es) 2009-11-18

Family

ID=40452546

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP080103941A AR068408A1 (es) 2007-09-14 2008-09-11 Pulverizacion de hormonas transdermicas

Country Status (6)

Country Link
US (1) US20090075963A1 (es)
AR (1) AR068408A1 (es)
CA (1) CA2699632A1 (es)
CL (1) CL2008002721A1 (es)
PE (1) PE20090680A1 (es)
WO (1) WO2009036355A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20110094858A (ko) * 2010-02-18 2011-08-24 에스케이케미칼주식회사 피부 자극이 감소한 톨테로딘의 경피 투여용 조성물
GB201200062D0 (en) 2012-01-04 2012-02-15 Innotesto Bvba Estradiol oromucosal liquid compositions
WO2014100599A1 (en) 2012-12-21 2014-06-26 Teikoku Pharma Usa, Inc. Compositions and methods for transdermal delivery of hormones and other medicinal agents
WO2019140087A1 (en) 2018-01-10 2019-07-18 Celista Pharmaceuticals Llc Testosterone transdermal spray with film
US12186326B2 (en) 2018-07-05 2025-01-07 Celista Pharmaceuticals Llc Testosterone and estradiol transdermal spray

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4978532A (en) * 1989-08-11 1990-12-18 Pharmedic Co. Dosage form for administration of dehydroepiandrosterone
US5198223A (en) * 1990-10-29 1993-03-30 Alza Corporation Transdermal formulations, methods and devices
US5304368A (en) * 1993-02-19 1994-04-19 American Telecast Corporation Non-foaming, non-viscous, alcohol-free, water-based, pressurized hair spray product
US5624060A (en) * 1995-05-02 1997-04-29 Ellion; M. Edmund Invertible dispensing system and dip tube
US6916487B2 (en) * 1996-02-19 2005-07-12 Acrux Dds Pty Ltd Transdermal delivery of antiemetics
US7094422B2 (en) * 1996-02-19 2006-08-22 Acrux Dds Pty Ltd. Topical delivery of antifungal agents
US6998138B2 (en) * 1996-02-19 2006-02-14 Acrux Dds Pty. Ltd. Topical delivery of anti-alopecia agents
US6929801B2 (en) * 1996-02-19 2005-08-16 Acrux Dds Pty Ltd Transdermal delivery of antiparkinson agents
US6916486B2 (en) * 1996-02-19 2005-07-12 Acrux Dds Pty Ltd Transdermal delivery of analgesics
AUPN814496A0 (en) * 1996-02-19 1996-03-14 Monash University Dermal penetration enhancer
US6923983B2 (en) * 1996-02-19 2005-08-02 Acrux Dds Pty Ltd Transdermal delivery of hormones
FR2758479B1 (fr) * 1997-01-20 1999-03-26 Valois Dispositif pour distribuer un produit fluide ou pulverulent a une distance predeterminee
US5912240A (en) * 1997-04-10 1999-06-15 Loria; Roger M. 5-androstene 3β, 17α diol as an inhibitor of tumor growth
US20040044080A1 (en) * 1997-10-28 2004-03-04 Place Virgil A. Treatment of dyspareunia with topically administered nitroglycerin formulations
US6113008A (en) * 1998-08-20 2000-09-05 3M Innovative Properties Company Actuator system for spraying a formulation onto a host
EP1323430B1 (en) * 2000-08-03 2007-03-14 Antares Pharma IPL AG Composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels
AUPR184500A0 (en) * 2000-12-01 2001-01-04 Drug Delivery Solutions Pty Ltd Dispensing device
KR20100055542A (ko) * 2002-06-25 2010-05-26 애크럭스 디디에스 피티와이 리미티드 비정질 약학적 조성물을 이용한 경피전달속도의 제어
US20050181032A1 (en) * 2002-06-25 2005-08-18 Acrux Dds Pty Ltd. Metastable pharmaceutical compositions
US20050186141A1 (en) * 2002-06-25 2005-08-25 Acrux Dds Pty Ltd. Transdermal aerosol compositions
US7820145B2 (en) * 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
FR2856301B1 (fr) * 2003-06-23 2007-08-03 Galderma Res & Dev Composition sous forme de spray comprenant un actif pharmaceutique, au moins un silicone volatile et une phase non polaire non volatile
DK1670433T3 (da) * 2003-10-10 2012-03-12 Ferring Bv Transdermal farmaceutisk formulering til mindskelse af hudrester
CN1886171A (zh) * 2003-11-28 2006-12-27 艾克若克斯Dds有限公司 快速经皮施用的方法和系统
CN1889994A (zh) * 2003-12-10 2007-01-03 艾克若克斯Dds有限公司 伴随透皮或局部药物输送的不希望的效果的治疗方法
US20070189977A1 (en) * 2004-06-07 2007-08-16 Jie Zhang Spray-on formulations and methods for dermal delivery of drugs
PT2214643E (pt) * 2007-11-02 2014-05-26 Acrux Dds Pty Ltd Sistema de entrega transdérmica para hormonas e esteroides

Also Published As

Publication number Publication date
CL2008002721A1 (es) 2008-12-19
CA2699632A1 (en) 2009-03-19
US20090075963A1 (en) 2009-03-19
PE20090680A1 (es) 2009-06-19
WO2009036355A1 (en) 2009-03-19

Similar Documents

Publication Publication Date Title
AR068408A1 (es) Pulverizacion de hormonas transdermicas
ES2500064T3 (es) Composiciones básicas que comprenden un alcanol y una sal de ácido graso o un glicérido de ácido graso para esterilizar un material
AR030312A1 (es) Composicion novedosa para la administracion transdermica y/o transmucosica de compuestos activos, que asegura adecuados niveles terapeuticos
RU2010114233A (ru) Применение гидрофобин-полипептидов в качестве усилителя пенетрации
ES2195798T1 (es) Formulacion para mujeres menopausicas.
UA102477C2 (en) Capsule composition
PE20120322A1 (es) Composicion farmaceutica que comprende faldaprevir o una sal del mismo en un vehiculo auto-emulsionante
CY1120888T1 (el) Διαδερμικες φαρμακευτικες συνθεσεις περιλαμβανοντας ενεργους παραγοντες
RU2013158010A (ru) Аппликаторная система для нанесения вязкой жидкости на кожу человека
BR0317876A (pt) Composições de liberação de droga tópica estáveis
UY24737A1 (es) Composiciones cosmeticas
MX354647B (es) Composicion farmaceutica anticonvulsiva transnasal que comprende un anticonvulsivante escasamente soluble.
AR037081A1 (es) Composicion para el suministro transdermico de fentanilo
MX2009004246A (es) Composiciones antimicrobianas.
ES2184079T3 (es) Agentes para la lucha contra insectos y acaros parasitantes en seres humanos.
PE20070210A1 (es) Compuestos macrociclicos como inhibidores del virus de hepatitis c
MY144341A (en) Lipid-improving agent and composition containing lipid-improving agent
PE20050919A1 (es) Agente endoparasiticida para administracion topica
CL2011001225A1 (es) Formulacion farmaceutica en solucion acuosa que comprende desde 1% hasta 5% (p/v) de una sal de diclofenaco, desde 3% hasta 30% (p/v) de al menos un polioxialquilen ester de hidroxido de acido graso y un co-solvente seleccionado de etanol, propanol, glicerol, propilenglicol entre otros.
PE20121359A1 (es) Composicion farmaceutica que comprende oligopeptidos
CO5031299A1 (es) Composiciones antitranspirantes
AR054381A1 (es) Metodo de lberacion controlada de una droga a traves de la piel
ITMI991747A0 (it) Dispositivo per erogazione spray di una composizione per applicazione topica comprendente vitamina e e acidi grassi essenziali
AR064262A1 (es) Composiciones farmaceuticas liquidas que comprenden un compuesto bisfosfonato
DE60106406D1 (de) Zubereitungen zur anwendung als penetrationförderer in transdermalen arzneimitteln die hoch-lipophile wirkstoffe enthalten

Legal Events

Date Code Title Description
FB Suspension of granting procedure